+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

B-Cell Non-Hodgkin's Lymphoma: Epidemiology Forecast to 2033 - Product Thumbnail Image

B-Cell Non-Hodgkin's Lymphoma: Epidemiology Forecast to 2033

  • Report
  • March 2025
  • 55 Pages
  • Global
From
Ewing Sarcoma - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Ewing Sarcoma - Global Clinical Trials Review, 2025

  • Clinical Trials
  • January 2025
  • 352 Pages
  • Global
From
From
Chondrosarcoma: Competitive Landscape - Product Thumbnail Image

Chondrosarcoma: Competitive Landscape

  • Report
  • July 2024
  • 63 Pages
  • Global
From
Ovarian Cancer Pipeline Analysis Report - Product Thumbnail Image

Ovarian Cancer Pipeline Analysis Report

  • Report
  • August 2024
  • 150 Pages
  • Global
From
Breast Cancer Pipeline Analysis Report - Product Thumbnail Image

Breast Cancer Pipeline Analysis Report

  • Report
  • August 2024
  • 150 Pages
  • Global
From
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more